Trial Summary
What is the purpose of this trial?The investigators wish to determine if application of 2% lidocaine soaked gauze to the peritonsillar pillars will decrease the amount of gagging caused by awake videolaryngocope assisted tracheal intubation in the morbidly obese.
Eligibility Criteria
This trial is for morbidly obese patients who are scheduled for bariatric surgery and require an awake intubation. Participants must be able to communicate in English or French, have no allergies to study drugs, and have an American Society of Anesthesiologists score less than 4.Exclusion Criteria
My health is severely limited and I am at high risk for surgery.
I cannot communicate in English or French.
Participant Groups
The study is testing whether applying a gauze soaked with 2% lidocaine to the throat area can reduce gagging during awake tracheal intubation using a videolaryngoscope in morbidly obese individuals.
2Treatment groups
Experimental Treatment
Placebo Group
Group I: LidocaineExperimental Treatment1 Intervention
Patients in this arm will have gauze soaked with lidocaine applied to the peritonsillar pillars.
Group II: SalinePlacebo Group1 Intervention
Application of saline to the glossopharyngeal nerve.
Lidocaine is already approved in United States, European Union, Canada for the following indications:
🇺🇸 Approved in United States as Lidocaine for:
- Local anesthesia for minor surgical procedures
- Surface anesthesia for minor procedures
- Spinal anesthesia
- Epidural anesthesia
🇪🇺 Approved in European Union as Lidocaine for:
- Local anesthesia
- Regional anesthesia
- Surface anesthesia
🇨🇦 Approved in Canada as Lidocaine for:
- Local anesthesia
- Regional anesthesia
Find A Clinic Near You
Research locations nearbySelect from list below to view details:
Royal Victoria HospitalMontreal, Canada
Loading ...
Who is running the clinical trial?
Royal Victoria Hospital, CanadaLead Sponsor